Evercore ISI downgraded Bio-Techne (TECH) to In Line from Outperform with a price target of $62, down from $68.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- Klaviyo, Wingstop among Stephens Best Ideas for 2026
- Bio-Techne price target raised to $72 from $66 at Deutsche Bank
- Bio-Techne announces collaboration with Wyss Center for Bio and Neuroengineering
- Bio-Techne price target raised to $68 from $65 at Argus
- Bio-Techne announces licensing agreement with Monod Bio